APLS Q1 2020 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$142,000

Operating Income

-$99M

Net Income

-$169M

EPS (Diluted)

$-2.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$109M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$689M

Total Liabilities

$430M

Stockholders' Equity

$259M

Cash & Equivalents

$418M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$142,000	-$49M	+99.7%
Operating Income	-$99M	-$49M	-103.1%
Net Income	-$169M	-$51M	-233.8%